Nabiximols clinical trials
Also written Sativex and GW-1000-02.
How each study uses nabiximols is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the nabiximols studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
60 studies that test it; most in 2002 (9)
| Year | Studies |
|---|---|
| 2001 | 4 |
| 2002 | 9 |
| 2005 | 5 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 6 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 45 · Other 16
Jazz Pharmaceuticals (35) · GW Pharmaceuticals Ltd (7) · Centre for Addiction and Mental Health (2) · McMaster University (1) · Ove Andersen (1) · University of California, San Diego (1) · Hannover Medical School (1) · King's College London (1)
Often tested with
Tested in the same studies.
Dronabinol (3) · GW-2000-02 (2) · Cannabidiol (2) · Cannabinol (1) · Methadone (1)
Related medicines
As reviewed, each with the page that says it.
- One of Analgesics source
Studies
Open first, then newest update. How each study uses nabiximols is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 61
- Proof of Concept Trial of Cannabis Derivatives in Neuropathic PainRecruitingPhase 2VA Office of Research and DevelopmentNCT05351801Written as THC + CBD (Nabiximols)How we know
- Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan)CompletedPhase 1Ove AndersenNCT05503147Written as SativexHow we know
- A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum DisordersWithdrawnPhase 2Michael, Levy M.D.,Ph.D.NCT05974293Written as NabiximolsHow we know
- Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple SclerosisTerminatedPhase 3Jazz PharmaceuticalsNCT04984278Written as NabiximolsHow we know
- The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and CannabidiolActive, not recruitingPhase 1McMaster UniversityNCT05742724Written as Tetrahydrocannabinol-Cannabidiol CombinationHow we know
- Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple SclerosisTerminatedPhase 3Jazz PharmaceuticalsNCT04203498Written as NabiximolsHow we know
- The Effect of Cannabis in Pancreatic CancerWithdrawnPhase 2Jens Rikardt AndersenNCT03245658Written as THC and CBD MixtureHow we know
- Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple SclerosisCompletedPhase 3Jazz PharmaceuticalsNCT04657666Written as NabiximolsHow we know
- Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple SclerosisCompletedPhase 3Jazz PharmaceuticalsNCT00702468Written as SativexHow we know
- A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.CompletedPhase 3Jazz PharmaceuticalsNCT00711646Written as Sativex®How we know
- A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)CompletedPhase 3Jazz PharmaceuticalsNCT00681538Written as Sativex®How we know
- A Study of the Long-term Safety of Sativex UseCompletedPhase 3Jazz PharmaceuticalsNCT01606137Written as GW-1000-02How we know
- Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related PainCompletedPhase 3Jazz PharmaceuticalsNCT00675948Written as SativexHow we know
- A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple SclerosisCompletedPhase 3Jazz PharmaceuticalsNCT00678795Written as Sativex®How we know
- A Study to Compare the Safety and Tolerability of Sativex® in Patients With Neuropathic Pain.CompletedPhase 3Jazz PharmaceuticalsNCT00713323Written as Sativex®How we know
- A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic PainCompletedPhase 3Jazz PharmaceuticalsNCT00713817Written as Sativex®How we know
- A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple SclerosisCompletedPhase 3Jazz PharmaceuticalsNCT01599234Written as SativexHow we know
- A Study of Sativex® for Pain Relief Due to Diabetic NeuropathyCompletedPhase 3Jazz PharmaceuticalsNCT00710424Written as SativexHow we know
- A Study of Sativex® for Pain Relief in Patients With Advanced MalignancyCompletedPhase 3Jazz PharmaceuticalsNCT00674609Written as Sativex®How we know
- A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With AllodyniaCompletedPhase 3Jazz PharmaceuticalsNCT00710554Written as SativexHow we know
See all 61 studies that test nabiximols →
Given beside what is tested · 1 — nabiximols is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with nabiximols
- Comparison of Safety, Tolerability and Pharmacokinetics of Medical Grade Cannabis (MGC) Orally Disintegrating Tablets With Buccal Sativex®, in Healthy Adult VolunteersCompletedPhase 1One World Cannabis Ltd.NCT03936907Written as SativexHow we know
- 5-Way Crossover Study to Compare the Safety, Tolerability and Pharmacokinetics of New Oral Cannabinoid Formulations Administered as Single Doses, With Buccal Sativex®, in Healthy VolunteersCompletedPhase 1PhytoTech Therapeutics, Ltd.NCT03201835Written as SativexHow we know
- Bioequivalence Assessment of Oral Administration Vs. Oral Spray of a Cannabinoids (Tetrahydrocannabinol and Cannabidiol)CompletedPhase 1Hadassah Medical OrganizationNCT01893424Written as Sativex buccal sprayHow we know
Codes
What other systems call nabiximols · ClinicalTrials.gg INT006460
- MeSH (NLM) C587251nabiximolsConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) K4H93P747ONABIXIMOLSConfirmed FDA, NLM, Wikidata
- Wikidata Q891968nabiximolsConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C71037NabiximolsOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C587251 | nabiximols | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | K4H93P747O | NABIXIMOLS | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q891968 | nabiximols | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C71037 | Nabiximols | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.